Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Revenue:
Sales revenue	$ 7,362	$ 200
Grant revenue	1,442
Total revenues	8,804	200
Cost of revenue:
Cost of sales	5,762	417
Cost of grant revenue	3,177
Provision for contract losses	508
Total cost of revenue	9,447	417
Gross loss	(643)	(217)
Selling, general, and administrative	29,844	3,713
Research and development	13,478	3,583
Total operating expenses	43,322	7,296
Operating loss	(43,965)	(7,513)
Interest income (expense), net	634	(3)
SAFE Instruments remeasurement	(86,907)
Warrant remeasurement	(6,651)	(7)
Other (expense) income, net	(517)	86
Net loss before taxes	(137,406)	(7,437)
Provision for income taxes	(2)
Net loss	(137,408)	(7,437)
Unrealized losses on available-for-sale securities	(17)
Cumulative translation adjustment	13
Total comprehensive loss	$ (137,412)	$ (7,437)
Loss per share – Basic and Diluted (in Dollars per share)	$ (11.48)	$ (0.93)
Weighted average number of shares outstanding – Basic and Diluted (in Shares)	11,970,550	7,978,512